These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32233403)

  • 1. Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M
    She X; Pegoli A; Gruber CG; Wifling D; Carpenter J; Hübner H; Chen M; Wan J; Bernhardt G; Gmeiner P; Holliday ND; Keller M
    J Med Chem; 2020 Apr; 63(8):4133-4154. PubMed ID: 32233403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M
    Pegoli A; She X; Wifling D; Hübner H; Bernhardt G; Gmeiner P; Keller M
    J Med Chem; 2017 Apr; 60(8):3314-3334. PubMed ID: 28388054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M
    She X; Pegoli A; Mayr J; Hübner H; Bernhardt G; Gmeiner P; Keller M
    ACS Omega; 2017 Oct; 2(10):6741-6754. PubMed ID: 30023530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M
    Weinhart CG; Wifling D; Schmidt MF; Neu E; Höring C; Clark T; Gmeiner P; Keller M
    Eur J Med Chem; 2021 Mar; 213():113159. PubMed ID: 33571911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Click Chemistry-Enabled Conjugation Strategy for Producing Dibenzodiazepinone-Type Fluorescent Probes To Target M
    Yang H; Micovic N; Monaghan JR; Clark HA
    Bioconjug Chem; 2022 Nov; 33(11):2223-2233. PubMed ID: 36327428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
    Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
    Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M
    Pegoli A; Wifling D; Gruber CG; She X; Hübner H; Bernhardt G; Gmeiner P; Keller M
    J Med Chem; 2019 Jun; 62(11):5358-5369. PubMed ID: 31074983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivity.
    Schmitz J; van der Mey D; Bermudez M; Klöckner J; Schrage R; Kostenis E; Tränkle C; Wolber G; Mohr K; Holzgrabe U
    J Med Chem; 2014 Aug; 57(15):6739-50. PubMed ID: 25051097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
    Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
    Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy.
    Mazzone SB; Mori N; Burman M; Palovich M; Belmonte KE; Canning BJ
    J Physiol; 2006 Aug; 575(Pt 1):23-35. PubMed ID: 16728454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
    Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
    Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
    Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high M
    Gruber CG; Pegoli A; Müller C; Grätz L; She X; Keller M
    RSC Med Chem; 2020 Jul; 11(7):823-832. PubMed ID: 33479678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRET- and fluorescence anisotropy-based assays for real-time monitoring of ligand binding to M
    Grätz L; Laasfeld T; Allikalt A; Gruber CG; Pegoli A; Tahk MJ; Tsernant ML; Keller M; Rinken A
    Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118930. PubMed ID: 33347921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
    Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
    Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
    Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.
    May LT; Lin Y; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists.
    Liu H; Hofmann J; Fish I; Schaake B; Eitel K; Bartuschat A; Kaindl J; Rampp H; Banerjee A; Hübner H; Clark MJ; Vincent SG; Fisher JT; Heinrich MR; Hirata K; Liu X; Sunahara RK; Shoichet BK; Kobilka BK; Gmeiner P
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12046-12050. PubMed ID: 30404914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.